Trade Summary

5 days ago, Belanoff Joseph K, serving as CEO at Corcept Therapeutics Inc (CORT), sold 40,000 shares at $50.10 per share, for a total transaction value of $2,003,860.00. Following this transaction, Belanoff Joseph K now holds 2,878,326 shares of CORT.

This sale represents a 1.00% decrease in Belanoff Joseph K's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 4 days after the trade was made.

Corcept Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.